134 related articles for article (PubMed ID: 11558535)
21. Evaluation of cytoreductive efficacy of vincristine, cyclophosphamide, and Doxorubicin in dogs with lymphoma by measuring the number of neoplastic lymphoid cells with real-time polymerase chain reaction.
Sato M; Yamazaki J; Goto-Koshino Y; Takahashi M; Fujino Y; Ohno K; Tsujimoto H
J Vet Intern Med; 2011; 25(2):285-91. PubMed ID: 21314729
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers.
Pegram M; Hsu S; Lewis G; Pietras R; Beryt M; Sliwkowski M; Coombs D; Baly D; Kabbinavar F; Slamon D
Oncogene; 1999 Apr; 18(13):2241-51. PubMed ID: 10327070
[TBL] [Abstract][Full Text] [Related]
23. Experimental combination chemotherapy of pirarubicin with various antitumor drugs against P388 murine leukemia.
Izumi H; Hirano S; Matsushita Y; Iguchi H; Tone H; Takeuchi T
Cancer Biochem Biophys; 1994 Sep; 14(2):137-49. PubMed ID: 7889494
[TBL] [Abstract][Full Text] [Related]
24. [Evaluation of combination chemotherapy with 5-FU, CDDP and CPT-11 for human gastric carcinoma transplanted into nude mice - comparative study of in vivo chemosensitivity test].
Kanamori N; Fujii M; Kochi M; Kaiga T; Takahashi T; Takayama T
Gan To Kagaku Ryoho; 2007 Jun; 34(6):881-4. PubMed ID: 17565250
[TBL] [Abstract][Full Text] [Related]
25. The proteasome inhibitor PS-341 in cancer therapy.
Teicher BA; Ara G; Herbst R; Palombella VJ; Adams J
Clin Cancer Res; 1999 Sep; 5(9):2638-45. PubMed ID: 10499643
[TBL] [Abstract][Full Text] [Related]
26. Responsiveness of human lung cancer/nude mouse to antitumor agents in a model using clinically equivalent doses.
Tashiro T; Inaba M; Kobayashi T; Sakurai Y; Maruo K; Ohnishi Y; Ueyama Y; Nomura T
Cancer Chemother Pharmacol; 1989; 24(3):187-92. PubMed ID: 2544308
[TBL] [Abstract][Full Text] [Related]
27. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.
Kim R; Tanabe K; Inoue H; Toge T
Int J Oncol; 2002 Mar; 20(3):549-55. PubMed ID: 11836567
[TBL] [Abstract][Full Text] [Related]
28. Anticancer chemosensitivity changes between the original and recurrent tumors after successful chemotherapy selected according to the sensitivity assay.
Nio Y; Tamura K; Tsubono M; Kawabata K; Masai Y; Hayashi H; Ishigami S; Araya S; Imamura M
Ann Surg; 1995 Jan; 221(1):89-99. PubMed ID: 7826166
[TBL] [Abstract][Full Text] [Related]
29. Modification of the antitumor activity of chemotherapeutic drugs by the hypoxic cytotoxic agent tirapazamine.
Dorie MJ; Brown JM
Cancer Chemother Pharmacol; 1997; 39(4):361-6. PubMed ID: 9025778
[TBL] [Abstract][Full Text] [Related]
30. Doxorubicin-loaded polysaccharide nanoparticles suppress the growth of murine colorectal carcinoma and inhibit the metastasis of murine mammary carcinoma in rodent models.
Li M; Tang Z; Zhang D; Sun H; Liu H; Zhang Y; Zhang Y; Chen X
Biomaterials; 2015 May; 51():161-172. PubMed ID: 25771007
[TBL] [Abstract][Full Text] [Related]
31. [Apoptosis-inducing and anti-tumor effect of cyclophosphamide, cisplatin and adriamycin used separately or combined in murine lymphosarcoma LS].
Nikolin VP; Kaledin VI; Baĭmak TIu; Galiamova MR; Popova NA; Voĭtsitskiĭ VE
Vopr Onkol; 2002; 48(2):211-5. PubMed ID: 12227071
[TBL] [Abstract][Full Text] [Related]
32. The antitumor effect of lowered doses of cytostatics combined with new analogs of vitamin D in mice.
Wietrzyk J; Nevozhay D; Filip B; Milczarek M; Kutner A
Anticancer Res; 2007; 27(5A):3387-98. PubMed ID: 17970085
[TBL] [Abstract][Full Text] [Related]
33. [A case of pneumonitis induced by CDDP and 5-FU].
Hirano A; Tanimoto Y; Kimura G; Kiura K; Ueoka H; Kataoka M; Tanimoto M
Nihon Kokyuki Gakkai Zasshi; 2005 May; 43(5):323-7. PubMed ID: 15969216
[TBL] [Abstract][Full Text] [Related]
34. Combination chemotherapy with nedaplatin and cyclophosphamide in human ovarian cancer model.
Uchida N; Yoshida H; Yamada H; Wada T; Daikatsu K; Ikeuchi I; Maekawa R; Sugita K; Yoshioka T
Jpn J Cancer Res; 1999 Aug; 90(8):887-94. PubMed ID: 10543262
[TBL] [Abstract][Full Text] [Related]
35. Cicaprost does not affect tumor inhibitory potential of cytostatic drugs.
Schirner M; Schneider M
Anticancer Res; 1993; 13(3):743-6. PubMed ID: 8317906
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of clinical presentation, induction and rescue treatment in 42 cases of canine centroblastic diffuse large B-cell multicentric lymphoma in the United Kingdom.
Davies O; Szladovits B; Polton G; Garden OA; Leo C; Lara-Garcia A
Vet Comp Oncol; 2018 Jun; 16(2):276-287. PubMed ID: 29271043
[TBL] [Abstract][Full Text] [Related]
37. Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.
Elliott WL; Roberts BJ; Howard CT; Leopold WR
Cancer Res; 1994 Aug; 54(16):4412-8. PubMed ID: 8044790
[TBL] [Abstract][Full Text] [Related]
38. Chemotherapy versus chemotherapy plus radiotherapy in the treatment of tonsillar squamous cell carcinoma in the dog.
Brooks MB; Matus RE; Leifer CE; Alfieri AA; Patnaik AK
J Vet Intern Med; 1988; 2(4):206-11. PubMed ID: 3230560
[TBL] [Abstract][Full Text] [Related]
39. Transplantable mouse mammary adenocarcinoma 16/c as a model in experimental cancer therapy. III. Sensitivity to antitumor drugs.
Rak J; Kuśnierczyk H; Strzadała L; Kłosiewicz S; Radzikowski C
Arch Immunol Ther Exp (Warsz); 1989; 37(3-4):389-97. PubMed ID: 2639635
[TBL] [Abstract][Full Text] [Related]
40. A new quinoline derivative MS-209 reverses multidrug resistance and inhibits multiorgan metastases by P-glycoprotein-expressing human small cell lung cancer cells.
Nokihara H; Yano S; Nishioka Y; Hanibuchi M; Higasida T; Tsuruo T; Sone S
Jpn J Cancer Res; 2001 Jul; 92(7):785-92. PubMed ID: 11473730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
